Back to News
Market Impact: 0.45

The Best Artificial Intelligence (AI) Stock to Buy Now

MSFTNVDAINTCGOOGLGOOGNFLXNDAQ
Artificial IntelligenceTechnology & InnovationCompany FundamentalsCorporate EarningsCorporate Guidance & OutlookAnalyst InsightsInvestor Sentiment & PositioningProduct Launches
The Best Artificial Intelligence (AI) Stock to Buy Now

Microsoft, which owns a reported 27% stake in OpenAI, has seen its shares fall more than 20% amid concerns about OpenAI's heavy cash burn and competitive pressures, even as OpenAI pursues up to $100 billion in funding. Despite the risks, Microsoft posted a solid quarter with Azure revenue up 26% year-over-year to $51.5 billion and a commercial backlog that rose 110% to $625 billion—management disclosed OpenAI represents roughly 45% of Azure's order backlog. The shares trade at about 25x earnings, the lowest valuation since late 2022, while analysts forecast roughly 14–15% annual EPS growth over the next 3–5 years, supporting the article's view that the pullback could present a buying opportunity.

Analysis

Market structure: Microsoft is a dual-benefit and single-point-of-failure story — it captures disproportionate upside if OpenAI funds and monetizes (Azure order-backlog exposure ~45%; commercial backlog $625B, Azure revenue +26% YoY to $51.5B) but faces concentrated counterparty risk. Winners include NVDA (increased GPU demand), cloud infra suppliers, and ISVs integrating OpenAI; losers are legacy CPU-focused vendors (INTC) and smaller cloud-native players who lose pricing power as hyperscalers bundle AI services. Expect higher gross margins for hardware/software providers and increased price-insensitivity for mission-critical AI cloud capacity over 12–36 months. Risk assessment: Tail risks include OpenAI failing to raise ~$100B in the next 30–90 days leading to a potential 10–20% hit to Azure revenue over 12 months, regulatory/antitrust actions targeting the Microsoft–OpenAI tie-up within 6–18 months, or a major model/data breach causing writedowns and reputational loss. Near-term (days–weeks): headline-driven volatility around fundraising updates and guidance; short-term (months): re-rating if Azure loses or gains large AI contracts; long-term (years): structural margins and share gains if Microsoft monetizes AI across enterprise stacks. Hidden dependencies: Azure’s order-book concentration, commercial contract terms, and Microsoft’s balance-sheet willingness to backstop OpenAI funding. Trade implications: Primary direct play is a risk-managed long in MSFT sized 2–3% of portfolio with explicit hedges (short-dated puts or collars) and a secondary hardware long in NVDA 1–2% to capture AI infrastructure upside. Relative-value: pair long MSFT / short INTC (or INTC put-spread) to express platform vs legacy compute divergence. Options: use 12–18 month LEAPS calls on MSFT for convex upside, financed by 3-month 5–10% OTM short puts or a covered-call collar to limit downside. Entry/exit: add on failure-to-raise signal or Azure guidance miss; scale into positions on >10% further pullback, trim on +25–35% rally. Contrarian angles: Consensus overweights the OpenAI risk and underweights Microsoft’s entrenched cash flows (Office/365, LinkedIn, Windows) that can fund AI investments — worst-case OpenAI impairment is absorbable without insolvency. The market may be over-discounting MSFT’s valuation (now ~25x forward) relative to 14–15% EPS growth consensus; if OpenAI secures capital in 30–90 days or Azure guidance holds, a rapid 20–35% mean-reversion is plausible. Historical parallel: 2016 cloud skepticism priced AWS-concentration risk despite durable revenue streams; unintended consequence of the bearish thesis is missing a multi-year AI platform winner while overexposing to cyclical chip cyclicality (INTC).